期刊文献+

幽门螺杆菌相关性胃炎和幽门螺杆菌非相关性胃炎中淋巴滤泡的意义 被引量:1

SIGNIFICANCE OF LYMPHOID FOLLICLES IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS AND HELICOBACTER PYLORI NONASSOCIATED GASTRITIS
下载PDF
导出
摘要 探讨幽门螺杆菌相关性胃炎中淋巴滤泡的发生率、分布及其相关病变,并评价其与临床病理学的关系。方法应用快速尿素酶试验、HE、W-S银染及AB-PAS染色技术进行分析。结果幽门螺杆菌相关性胃炎组(HPAG)的淋巴滤泡(LF)发生率非常显著地高于幽门螺杆菌非相关性胃炎组(HPNAG)(P<0.0001)。正常粘膜罕见LF。HPAG中的部分病人可见到LF扩大或融合、数量增加及滤泡中心细胞(FCC)核分裂指数增加。结论LF是HPAG的特征性有用标记。LF及淋巴细胞广泛浸润是胃粘膜局部免疫反应形式。LF及淋巴细胞过度增殖可能是胃原发性MALT淋巴瘤的危险因素。 Objective To investigate the prevalence and distribution and related lesions of lymphoid follicle (LF) in gastric biopsy specimens with Helicobacter pylori infection and to evaluate their relationship with clinical pathology.Methods Gastric biopsy specimens from 1798 cases of Helicobacter pylori associated gastritis(HPAG),382 cases of Helicobacter pylori nonassociated gastritis (HPNAG),220 cases of normal gastric mucosa were examined by HE,W-S,AB-PAS and fast urease test.Results Very marked difference in number of LF was found between HPAG and HPNAG (P<0.0001).Multiude of LF,expansion or confluence of LF,increased fission index of FCC (follicular center cells) were observed in some cases of HPAG.LF were seldomly seen in normal gastric mucosa.Conclusions LF is a conspicuous useful morphological marker for HPAG.LF and diffuse lymphocytic infiltration represent mucosal local immune reactions.Over hyperplasia of LF can be a risk factor of gastric MALT-lymphocytoma.
出处 《徐州医学院学报》 CAS 1997年第4期374-377,共4页 Acta Academiae Medicinae Xuzhou
关键词 淋巴滤泡 幽门螺杆菌 发生率 胃炎 HPAG LF Lymphoid follicle Helicobacter pylori associated gastritis Morphological useful marker Gastric MALT-lyphocytoma Immune reaction muccsal local
  • 相关文献

同被引文献11

  • 1张强英,余咏文,黄惠清,李鸣.儿童幽门螺杆菌感染与白细胞介素-8含量的关系[J].中国当代儿科杂志,2004,6(4):284-286. 被引量:4
  • 2张绍兰,杨致邦,毛小琴.抗幽门螺杆菌粘附素HpaA卵黄抗体的制备[J].中国人兽共患病学报,2006,22(3):265-267. 被引量:6
  • 3周慊.三联疗法治疗幽门螺旋杆菌相关性胃溃疡的疗效观察[J].医学临床研究,2006,23(2):265-266. 被引量:3
  • 4Aslan S, Yilmaz I, Bal N, et al. Investigation of ttelicobacter pylori in tonsiltary tissue with pronto dry test and pathologic examination [J]. Aurls Nasus Larynx, 2007, 31(3): 339-342.
  • 5Serrano C, Diaz M I, Valdivia A, et al. Relationship between Helicobacter pylori virulence factors and regulatory eytokines as predictors of clinical outcome [J]. Microbes and Infection, 2007, 9(4): :428-434.
  • 6Wolle K, Malfertheine P. Treatment of Helicobacter pylori [J]. Best Practice and Research Clinical Gastroenterology, 2007, 21(2) : 315-324.
  • 7Gulhan M, Canbakan S, Ahmed K, et al. Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue [J]. Archives of Medical Research, 2007, 38(3): 317- 321.
  • 8Ishak R A H, Awad G A S, Mortada N D, et al. Preparation, in vitro and vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy [J]. Journal of Controlled Release, 2007, 119(2): 207-214.
  • 9Rajinikanth P S, Balasubramaniam J, Mishra B. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori [J]. International Journal of Pharmaceutics, 2007, 335(1/2) : 114-122.
  • 10谢献胜,刘孟,李建基,刘俊栋,王健.卵黄抗体对幽门螺杆菌感染沙土鼠的预防试验[J].苏州大学学报(医学版),2007,27(5):715-717. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部